Distinguished in Prader-Willi Syndrome

Evelien F. Gevers

London, ENG, GB 
Distinguished in Prader-Willi Syndrome
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Evelien Gevers practices in London, United Kingdom. Ms. Gevers is rated as a Distinguished expert by MediFind in the treatment of Prader-Willi Syndrome. Her top areas of expertise are Prader-Willi Syndrome, Congenital Adrenal Hyperplasia (CAH), Short Stature (Growth Disorders), and Hypotonia.

Her clinical research consists of co-authoring 47 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles and participated in 2 clinical trials in the study of Prader-Willi Syndrome.

Gender
Female

Locations

London, ENG E11BB, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
Enrollment Status: Completed
Publish Date: April 19, 2024
Intervention Type: Drug
Study Drug: DCCR (diazoxide choline controlled release tablets)
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

47 Total Publications

Novel Insights into the Pathophysiology and Management of Obesity in Childhood and Adolescence.
Novel Insights into the Pathophysiology and Management of Obesity in Childhood and Adolescence.
Journal: Hormone research in paediatrics
Published: June 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gevers's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 15 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile